Onconetix, Inc.
Onconetix, Inc. (ONCO) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
onco · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Onconetix, Inc. (ONCO) measures how much investors pay for each dollar of the company's trailing earnings. ONCO's current PE ratio of N/A is calculated by dividing its stock price of $1.00 by its TTM earnings per share of -$15.44.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Onconetix, Inc.You ONCO | $0M | N/A | — | -$15.44 |
 Azitra, Inc. AZTR | $2M | N/A | — | -$2.25 |
 Enveric Biosciences, Inc. ENVB | $1M | N/A | — | -$36.24 |
 Indaptus Therapeutics, Inc. INDP | $4M | N/A | — | -$21.58 |
 Jasper Therapeutics, Inc. JSPR | $7M | N/A | — | -$3.95 |
 Protagenic Therapeutics, Inc. PTIX | $1M | N/A | — | -$2.66 |
 Revelation Biosciences, Inc. REVB | $4M | N/A | — | -$14.36 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-4.28 | — | |
2024-12-31 FY2024 | — | $-519.16 | — | |
2023-12-31 FY2023 | — | $-2124.10 | — | |
2022-12-31 FY2022 | — | $-1062.41 | — | |
2021-12-31 FY2021 | — | $-300.52 | — | |
2020-12-31 FY2020 | — | $-140.66 | — | |
2019-12-31 FY2019 | — | $-72.28 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Onconetix, Inc. (ONCO) measures how much investors pay for each dollar of the company's trailing earnings. ONCO's current PE ratio of N/A is calculated by dividing its stock price of $1.00 by its TTM earnings per share of -$15.44.
Frequently asked questions
ONCO pe ratio · 6 questionsONCO's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.00 and TTM EPS of -$15.44. Data sourced from Financial Modeling Prep via ONCO's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Onconetix, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09